secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0000950170-25-090183
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics regains full Nasdaq Capital Market compliance; Panel Monitor through June 2026
--------------------------------------------------------------------------------

- On June 24, 2025, Nasdaq confirmed compliance with minimum stockholders' equity (Rule 5550(b)(1)).
- Had previously regained compliance with bid price, public float, and market value rules on May 13, 2025.
- All listing criteria now met; previously disclosed compliance matters closed.
- Subject to Panel Monitor for one year through June 23, 2026; failure requires hearing not plan submission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025090183/0000950170-25-090183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025090183/hcwb-20250626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-090183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer